OWL-LABS
27.7.2021 09:02:07 CEST | Business Wire | Press release
Owl Labs , the award-winning leader in immersive and collaborative video conferencing technology and services, today announces its partnership with Bechtle , one of Europe’s leading IT providers and largest IT system house in Germany, to strengthen Owl Labs’ presence within key European markets and verticals. As a result of the partnership, Owl Labs can continue to expand the reach, awareness, and adoption of its award-winning flagship product, the Meeting Owl Pro, across Europe through Bechtle’s 80 locations in the DACH region and its e-commerce subsidiaries in 14 European countries, including: UK, Ireland, France, Germany, Netherlands, Belgium, Spain, Portugal, Italy, Poland, Hungary, Switzerland, Austria and Czech Republic.
Frank Weishaupt, CEO of Owl Labs says: “Business leaders across Europe are increasingly embracing hybrid work post-pandemic, with our recent State of Hybrid Work report revealing that 89% of business leaders across Europe plan on having a hybrid workforce post-pandemic. What’s more, 36% of European businesses are now investing in new communication tools and technology to help facilitate this permanent move to hybrid work. We are delighted to team up with Bechtle to meet this rapidly growing demand and make it easier for businesses and teams based in Europe to use Owl Labs’ collaboration technology to help maintain and facilitate clear and effective communication, no matter their location.”
Ascan Collier, Managing Director, Bechtle Logistik & Service says: “Workplaces are undergoing a profound transformation and businesses now require new tools to help accommodate the shift to hybrid working. As organisations adapt to new hybrid working policies, they must leverage new technology to ensure communication, collaboration and productivity are not compromised. As workplaces pivot to hybrid work and progressive policies, Owl Labs is a key partner to help our customers transform their workplaces to keep up with rapidly changing workplace policies.”
As hybrid work and remote teams become the norm, maintaining effective communication and collaboration between dispersed employees is of key importance to business leaders. The Meeting Owl Pro enables companies to achieve a seamless, collaborative and immersive team experience through its proprietary intelligent technology, which automatically focuses on who is speaking in a room using audio and visual cues from its high-definition 360° camera, as well as eight microphones and tri-speakers that have a pickup range of five meters.
--Ends--
About Owl Labs
Owl Labs is a collaborative technology company revolutionizing the way we connect. Owl Labs creates deeply immersive and inclusive meeting experiences for today’s hybrid workforce and virtual classroom. The company’s flagship product, the award-winning Meeting Owl, features a wifi-enabled, 360-degree camera, mic, and speaker powered by proprietary technology with an automatic zoom that responds to who’s speaking. In 2020, the Meeting Owl Pro was named in TIME’s 100 Best Innovations .
Owl Labs continues to champion the hybrid work movement with it’s annual State of Remote Work Report . To learn more about Owl Labs and the full product suite and to join the Work From Anywhere Movement, please visit www.owllabs.com .
About Bechtle:
Bechtle AG is one of Europe’s leading IT providers, with some 80 system houses in Germany, Austria and Switzerland as well 24 as e-commerce subsidiaries in 14 European countries. Founded in 1983, the company is headquartered in the southern German town of Neckarsulm and currently employs over 12,000 people. Bechtle provides more than 70,000 customers from the industrial, trade, financial and public sectors with a comprehensive, vendor-neutral portfolio that covers all aspects of IT infrastructure and operation. Bechtle is listed on the MDAX and TecDAX indexes. In 2020, the Group generated revenues of around 5.82 billion euros. Read more at: bechtle.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210727005113/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom